title: Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
authors.forename: J Howard
authors.initials: JH
authors.lastname: Jaster
authors.forename: Harvey B
authors.initials: HB
authors.lastname: Niell
authors.forename: F Curtis
authors.initials: FC
authors.lastname: Dohan
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Smith
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy; D015331:Cohort Studies; D003110:Colonic Neoplasms / Q000150:complications / Q000188:drug therapy; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000209:etiology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000150:complications; D008297:Male; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology*; D018239:Seminoma / Q000150:complications; D013736:Testicular Neoplasms / Q000150:complications
chemical_list: D000970:Antineoplastic Agents; D008942:Mitoxantrone